Pharmacognostic Profiling and Standardisation of Praxelis clematidea (Griseb): Morphological, Physicochemical, and Phytochemical Insights
Plant Biotechnology Persa · 2026
DOI: 10.66224/pbp.8.1.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant Biotechnology Persa, 2026. Verfasst von Tunde Owolabi und 1 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Objective
Praxelis clematidea (Asteraceae) has attracted medicinal interest but remains poorly characterized pharmacognostically.The lack of standardized data limits its therapeutic application and broader acceptance.Its variable phytochemical profile across regions underscores the need for a comprehensive pharmacognostic framework.This study provides foundational data for standardization, supporting reliable herbal preparation development, guiding pharmacological research, and differentiating it from morphologically similar Asteraceae species.
Methods
Macroscopic and microscopic analyses were performed to characterize tissues and cellular inclusions, and leaf constants were quantified.Physicochemical parameters, including ash values, extractive values, and moisture content, were assessed.Phytochemical screening and thin-layer chromatography (TLC) were used to detect secondary metabolites.Acute toxicity was evaluated in animal models to determine LD₅₀.
Results
P. clematidea displayed distinctive morphological and anatomical features.Quantitative microscopy recorded vein islets (20 ± 1.45), vein terminations (52 ± 5.27), and stomatal indices of 20 ± 1.25 (upper surface) and 18 ± 0.94 (lower surface).Physicochemical analysis revealed total ash 12.667 ± 0.219%, loss on drying 7.433 ± 0.636%, water-soluble extractive 8.967 ± 0.393%, and alcohol-soluble extractive 15.733 ± 0.561%.Phytochemical screening identified flavonoids, alkaloids, and terpenoids, with five TLC spots.Acute toxicity indicated moderate toxicity (LD₅₀ = 565.69mg/kg).
Conclusion
This study establishes standardized diagnostic parameters for P. clematidea, ensuring accurate identification and quality control.The characterized bioactive constituents highlight its medicinal potential, and toxicity assessment indicates preliminary safety for therapeutic use.These findings support its inclusion in pharmacopoeial monographs and safe application in herbal medicine.
Zitieren
APA
Owolabi, T., & Ayinde, B. A. (2026). Pharmacognostic Profiling and Standardisation of Praxelis clematidea (Griseb): Morphological, Physicochemical, and Phytochemical Insights. Plant Biotechnology Persa. https://doi.org/10.66224/pbp.8.1.15
Vancouver
Owolabi T, Ayinde BA. Pharmacognostic Profiling and Standardisation of Praxelis clematidea (Griseb): Morphological, Physicochemical, and Phytochemical Insights. Plant Biotechnology Persa. 2026. doi:10.66224/pbp.8.1.15
BibTeX
@article{Owolabi2026,
author = {Owolabi, Tunde and Ayinde, Buniyamin A},
title = {Pharmacognostic Profiling and Standardisation of Praxelis clematidea (Griseb): Morphological, Physicochemical, and Phytochemical Insights},
journal = {Plant Biotechnology Persa},
year = {2026},
doi = {10.66224/pbp.8.1.15}
}
EUVIMED